San Francisco-based Burrill & Company has completed a Series B round of financing in Bangalore-based Strand Life Sciences.
Burrill, a diversified global financial services firm focused on the life science industry, is the sole investor in this round, which included both a primary investment and a secondary buyout of the lead Series A investors.
The fresh infusion will be used to expand the company’s presence in precision diagnostics and reach into global markets.
The fresh infusion will be used to expand the company’s presence in precision diagnostics and reach into global markets.
From the Venture Intelligence PE Deal database: Strand had raised $2.7 M from UTI Ventures in Nov-01, and $1.9 M from Sequoia in Sep-02.
Source: Press Release
Are you at APEX?
Where The Stars Foretell the Future of Indian PE/VC
Are you Showcasing at APEX?
Don’t Miss Out on THE Most Effective Investor Networking Opportunity of the Year
http://ventureintelligence.blogspot.in/2013/01/crucial-connect-to-venture-capital.html
http://ventureintelligence.blogspot.in/2013/01/crucial-connect-to-venture-capital.html
